Cargando…

Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection – a comparative, retrospective analysis

BACKGROUND: Infections due to Respiratory Syncytial Virus (RSV) and Influenza virus (FLU) are leading causes of hospitalization in young children. Yet, there is little data on factors associated with antibiotic use in these patients. METHODS: We conducted a retrospective, single-center study of all...

Descripción completa

Detalles Bibliográficos
Autores principales: Papan, Cihan, Willersinn, Meike, Weiß, Christel, Karremann, Michael, Schroten, Horst, Tenenbaum, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430130/
https://www.ncbi.nlm.nih.gov/pubmed/32807104
http://dx.doi.org/10.1186/s12879-020-05336-5
_version_ 1783571379290898432
author Papan, Cihan
Willersinn, Meike
Weiß, Christel
Karremann, Michael
Schroten, Horst
Tenenbaum, Tobias
author_facet Papan, Cihan
Willersinn, Meike
Weiß, Christel
Karremann, Michael
Schroten, Horst
Tenenbaum, Tobias
author_sort Papan, Cihan
collection PubMed
description BACKGROUND: Infections due to Respiratory Syncytial Virus (RSV) and Influenza virus (FLU) are leading causes of hospitalization in young children. Yet, there is little data on factors associated with antibiotic use in these patients. METHODS: We conducted a retrospective, single-center study of all patients below 2 years of age hospitalized between 2014 and 2018. We compared children with RSV infection to children with FLU infection analyzing clinical characteristics and factors contributing to an increased rate of antimicrobial utilization. RESULTS: RSV infection was diagnosed in 476/573 (83.1%), FLU in 95/573 (16.6%), and RSV-FLU-co-infection in 2/573 (0.3%) patients. Median age was lower for RSV compared to FLU (4 vs. 12 months; p < 0.0001). Children with RSV had longer hospitalization (5 vs. 4 days; p = 0.0023) and needed oxygen more frequently (314/476 vs. 23/95; p < 0.0001) than FLU patients. There was no significant difference in the overall antibiotic utilization between RSV and FLU patients (136/476 vs. 21/95; p = 0.2107). Logistic regression analyses revealed that septic appearance on admission (odds ratio [OR] 8.95, 95% confidence interval [CI] 1.5–54.1), acute otitis media (OR 4.5, 95% CI 2.1–9.4), a longer oxygen therapy (OR 1.40; 95% CI 1.13–1.74) and a higher C-reactive protein (CRP) (OR 1.7, 95% CI 1.5–2.0) were significantly associated with antibiotic use in both groups, but not age or pneumonia. CONCLUSIONS: In our cohort, the rate of antibiotic utilization was comparable between RSV and FLU patients, while for both groups distinct clinical presentation and a high CRP value were associated with higher antibiotic use.
format Online
Article
Text
id pubmed-7430130
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74301302020-08-17 Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection – a comparative, retrospective analysis Papan, Cihan Willersinn, Meike Weiß, Christel Karremann, Michael Schroten, Horst Tenenbaum, Tobias BMC Infect Dis Research Article BACKGROUND: Infections due to Respiratory Syncytial Virus (RSV) and Influenza virus (FLU) are leading causes of hospitalization in young children. Yet, there is little data on factors associated with antibiotic use in these patients. METHODS: We conducted a retrospective, single-center study of all patients below 2 years of age hospitalized between 2014 and 2018. We compared children with RSV infection to children with FLU infection analyzing clinical characteristics and factors contributing to an increased rate of antimicrobial utilization. RESULTS: RSV infection was diagnosed in 476/573 (83.1%), FLU in 95/573 (16.6%), and RSV-FLU-co-infection in 2/573 (0.3%) patients. Median age was lower for RSV compared to FLU (4 vs. 12 months; p < 0.0001). Children with RSV had longer hospitalization (5 vs. 4 days; p = 0.0023) and needed oxygen more frequently (314/476 vs. 23/95; p < 0.0001) than FLU patients. There was no significant difference in the overall antibiotic utilization between RSV and FLU patients (136/476 vs. 21/95; p = 0.2107). Logistic regression analyses revealed that septic appearance on admission (odds ratio [OR] 8.95, 95% confidence interval [CI] 1.5–54.1), acute otitis media (OR 4.5, 95% CI 2.1–9.4), a longer oxygen therapy (OR 1.40; 95% CI 1.13–1.74) and a higher C-reactive protein (CRP) (OR 1.7, 95% CI 1.5–2.0) were significantly associated with antibiotic use in both groups, but not age or pneumonia. CONCLUSIONS: In our cohort, the rate of antibiotic utilization was comparable between RSV and FLU patients, while for both groups distinct clinical presentation and a high CRP value were associated with higher antibiotic use. BioMed Central 2020-08-17 /pmc/articles/PMC7430130/ /pubmed/32807104 http://dx.doi.org/10.1186/s12879-020-05336-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Papan, Cihan
Willersinn, Meike
Weiß, Christel
Karremann, Michael
Schroten, Horst
Tenenbaum, Tobias
Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection – a comparative, retrospective analysis
title Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection – a comparative, retrospective analysis
title_full Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection – a comparative, retrospective analysis
title_fullStr Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection – a comparative, retrospective analysis
title_full_unstemmed Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection – a comparative, retrospective analysis
title_short Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection – a comparative, retrospective analysis
title_sort antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection – a comparative, retrospective analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430130/
https://www.ncbi.nlm.nih.gov/pubmed/32807104
http://dx.doi.org/10.1186/s12879-020-05336-5
work_keys_str_mv AT papancihan antibioticutilizationinhospitalizedchildrenunder2yearsofagewithinfluenzaorrespiratorysyncytialvirusinfectionacomparativeretrospectiveanalysis
AT willersinnmeike antibioticutilizationinhospitalizedchildrenunder2yearsofagewithinfluenzaorrespiratorysyncytialvirusinfectionacomparativeretrospectiveanalysis
AT weißchristel antibioticutilizationinhospitalizedchildrenunder2yearsofagewithinfluenzaorrespiratorysyncytialvirusinfectionacomparativeretrospectiveanalysis
AT karremannmichael antibioticutilizationinhospitalizedchildrenunder2yearsofagewithinfluenzaorrespiratorysyncytialvirusinfectionacomparativeretrospectiveanalysis
AT schrotenhorst antibioticutilizationinhospitalizedchildrenunder2yearsofagewithinfluenzaorrespiratorysyncytialvirusinfectionacomparativeretrospectiveanalysis
AT tenenbaumtobias antibioticutilizationinhospitalizedchildrenunder2yearsofagewithinfluenzaorrespiratorysyncytialvirusinfectionacomparativeretrospectiveanalysis